Slide 1
Slide 2
Slide 3
Slide 4
*In clinical trials studying Wegovy® (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone). Results may vary. Compounded medications are not FDA-approved and are made by a licensed pharmacy based on a provider’s prescription.

PT-141

Provider-guided peptide support for sexual desire, arousal, and confidence in intimacy
Starting at $199/month
May support sexual desire and arousal
Helps support intimacy and responsiveness
May support confidence in intimate moments
PT-141 is a peptide offered with provider guidance for people looking to support sexual desire, arousal, and overall intimacy support. It may be a fit for those who want help feeling more responsive, more confident, and more connected in intimate moments. PT-141 is also known as bremelanotide, and an FDA-approved bremelanotide product, Vyleesi, is approved for acquired, generalized hypoactive sexual desire disorder in premenopausal women.
*In clinical trials studying Wegovy® (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone). Results may vary. Compounded medications are not FDA-approved and are made by a licensed pharmacy based on a provider’s prescription.
FAQ

What is PT-141 used for?

PT-141 is used with provider guidance to support sexual desire, arousal, and intimacy support.
FAQ

Who may be a good fit for PT-141?

It may be a fit for people looking for support with low sexual desire, low arousal, or feeling less responsive during intimacy.
FAQ

Do I need a prescription?

Yes. PT-141 treatment should be evaluated and prescribed by a licensed provider.
FAQ

How is PT-141 used?

PT-141 is commonly used as a subcutaneous injection. For FDA-approved bremelanotide, the approved product is an as-needed subcutaneous injection.
  Provider Supervised  •  FDA-Registered Pharmacy  •  Personalized Protocols  •  Evidence-Reviewed  •
 Provider Supervised  •  FDA-Registered Pharmacy  •  Personalized Protocols  •  Evidence-Reviewed  •
  Provider Supervised  •  FDA-Registered Pharmacy  •  Personalized Protocols  •  Evidence-Reviewed  •
What is PT-141?
PT-141 is a synthetic peptide used with provider guidance for people looking to support sexual desire, arousal, and intimacy. It works differently from treatments that focus mainly on blood flow because it acts through the central nervous system. Published clinical and review literature describe bremelanotide as a melanocortin receptor agonist developed for sexual desire support.

It may be a fit for people who want support with low desire, low arousal, or feeling less responsive during intimacy. If prescribed, a licensed provider will determine whether it is appropriate based on your health history, symptoms, and goals.

Benefit deep dive

Heading

Daily support to help maintain cellular energy.

Sexual desire support

PT-141 is designed to support sexual desire and intimacy for people who feel their interest in sex is lower than it used to be. FDA-approved bremelanotide is indicated for acquired, generalized hypoactive sexual desire disorder in premenopausal women.

Arousal and responsiveness

It may help support feeling more responsive and engaged in intimate moments. Clinical literature reports improvement in sexual desire and related distress with bremelanotide treatment in the studied population.

Confidence in intimacy

PT-141 is often chosen by people who want support with confidence, connection, and a better overall intimate experience.

Individual experiences vary. These statements describe general physiological roles of NAD+.

How PT-141 Works

Designed to support circulation and the body’s natural recovery pathways
1.
Works through the brain’s signaling pathways

PT-141 works through melanocortin pathways in the central nervous system rather than working like a typical blood-flow-focused treatment.

2.
Helps support desire and arousal

It is used by people looking for support with sexual desire, responsiveness, and feeling more interested in intimacy. Clinical studies of bremelanotide in premenopausal women with HSDD found improvements in desire and distress measures.

3.
Built for intimacy support

PT-141 is designed for people who want support with desire, arousal, and confidence in intimate settings as part of provider-guided care.

Your PT-141 plan, made simple

3-minute medical intake. Provider-led. 100% online.
Step 1
Complete your online consultation

You fill out a brief medical intake about your goals, symptoms, and health history. This helps your provider determine if PT-141 is appropriate for you.

Step 2
Provider review & personalized plan

A licensed clinician reviews your case and creates a tailored PT-141 plan based on your needs.

Step 3
Medication compounded & shipped to you

If approved, your PT-141 medication is prepared by a U.S.-based compounding pharmacy and delivered directly to your door.

Step 4
Ongoing support inside your Shed portal

Ask questions, request adjustments, and get support anytime from your care team.

Questions? Answers.

What is PT-141 used for?

PT-141 is used with provider guidance to support sexual desire, arousal, and intimacy support.

Who may be a good fit for PT-141?

It may be a fit for people looking for support with low sexual desire, low arousal, or feeling less responsive during intimacy.

Do I need a prescription?

Yes. PT-141 treatment should be evaluated and prescribed by a licensed provider.

How is PT-141 used?

PT-141 is commonly used as a subcutaneous injection. For FDA-approved bremelanotide, the approved product is an as-needed subcutaneous injection.